These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11809704)

  • 1. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.
    Zembutsu H; Ohnishi Y; Tsunoda T; Furukawa Y; Katagiri T; Ueyama Y; Tamaoki N; Nomura T; Kitahara O; Yanagawa R; Hirata K; Nakamura Y
    Cancer Res; 2002 Jan; 62(2):518-27. PubMed ID: 11809704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs.
    Udagawa C; Sasaki Y; Tanizawa Y; Suemizu H; Ohnishi Y; Nakamura Y; Tokino T; Zembutsu H
    PLoS One; 2020; 15(9):e0239614. PubMed ID: 32986753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
    Ooyama A; Takechi T; Toda E; Nagase H; Okayama Y; Kitazato K; Sugimoto Y; Oka T; Fukushima M
    Cancer Sci; 2006 Jun; 97(6):510-22. PubMed ID: 16734730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
    Nakatsu N; Yoshida Y; Yamazaki K; Nakamura T; Dan S; Fukui Y; Yamori T
    Mol Cancer Ther; 2005 Mar; 4(3):399-412. PubMed ID: 15767549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
    Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A
    Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.
    Dan S; Tsunoda T; Kitahara O; Yanagawa R; Zembutsu H; Katagiri T; Yamazaki K; Nakamura Y; Yamori T
    Cancer Res; 2002 Feb; 62(4):1139-47. PubMed ID: 11861395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839.
    Zembutsu H; Ohnishi Y; Daigo Y; Katagiri T; Kikuchi T; Kakiuchi S; Nishime C; Hirata K; Nakamura Y
    Int J Oncol; 2003 Jul; 23(1):29-39. PubMed ID: 12792773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies.
    Hollingshead MG; Stockwin LH; Alcoser SY; Newton DL; Orsburn BC; Bonomi CA; Borgel SD; Divelbiss R; Dougherty KM; Hager EJ; Holbeck SL; Kaur G; Kimmel DJ; Kunkel MW; Millione A; Mullendore ME; Stotler H; Collins J
    BMC Genomics; 2014 May; 15(1):393. PubMed ID: 24885658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.
    Imaizumi M; Kondo T; Taguchi T; Hattori T; Abe O; Kitano M; Wakui A
    Surg Today; 1993; 23(5):412-9. PubMed ID: 8324334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs.
    Udagawa C; Sasaki Y; Suemizu H; Ohnishi Y; Ohnishi H; Tokino T; Zembutsu H
    Exp Ther Med; 2018 Feb; 15(2):1339-1359. PubMed ID: 29434720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents.
    Inaba M; Tashiro T; Kobayashi T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T
    Jpn J Cancer Res; 1988 Apr; 79(4):517-22. PubMed ID: 3133340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
    Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
    Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.
    Takata R; Katagiri T; Kanehira M; Tsunoda T; Shuin T; Miki T; Namiki M; Kohri K; Matsushita Y; Fujioka T; Nakamura Y
    Clin Cancer Res; 2005 Apr; 11(7):2625-36. PubMed ID: 15814643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.
    Quintieri L; Fantin M; Vizler C
    Adv Exp Med Biol; 2007; 593():95-104. PubMed ID: 17265720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.
    Györffy B; Surowiak P; Kiesslich O; Denkert C; Schäfer R; Dietel M; Lage H
    Int J Cancer; 2006 Apr; 118(7):1699-712. PubMed ID: 16217747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance network between chemosensitivity and transcriptome in human hepatoma cells.
    Moriyama M; Hoshida Y; Otsuka M; Nishimura S; Kato N; Goto T; Taniguchi H; Shiratori Y; Seki N; Omata M
    Mol Cancer Ther; 2003 Feb; 2(2):199-205. PubMed ID: 12589037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status.
    Scott BJ; Qutob S; Liu QY; Ng CE
    Int J Cancer; 2009 Sep; 125(5):1193-204. PubMed ID: 19444912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles.
    Kihara C; Tsunoda T; Tanaka T; Yamana H; Furukawa Y; Ono K; Kitahara O; Zembutsu H; Yanagawa R; Hirata K; Takagi T; Nakamura Y
    Cancer Res; 2001 Sep; 61(17):6474-9. PubMed ID: 11522643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of transcriptome in cancer patient-derived xenografts.
    Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
    PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.